Neuroprotective role of angiotensin II type 2 receptor after transient focal ischemia in mice brain

Neuroscience Research

Volumn 61, Issue 3, 2008, Pages 249-256

  Miyamoto, Nobukazu ^a   Zhang, Ning ^a   Tanaka, Ryota ^a   Liu, Meizi ^a   Hattori, Nobutaka ^a   Urabe, Takao ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II type 1 receptor; Angiotensin II type 2 receptor; Anti apoptosis; Ischemia reperfusion injury; Valsartan

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; JANUS KINASE; PROTEIN BCL 2; STAT PROTEIN; STAT3 PROTEIN; VALSARTAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; APOPTOSIS; BRAIN; GENE EXPRESSION REGULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MALE; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; REPERFUSION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TETRAZOLES; TIME FACTORS; VALINE;

EID: 43949140831     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2008.03.003     Document Type: Article

References (25)

1. Brasier A.R., Recinos III A., and Eledrisi M.S. Vascular inflammation and the renin-angiotensin system. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1257-1266
2. Cosentino R., Savoia C., De Paolis P., Francia P., Russo A., Maffei A., Venturelli V., Schiavoni M., Lembo G., and Volpe M. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Am. J. Hypertens. 18 (2005) 493-499
3. Culman J., Baulmann J., Blume A., and Unger T. The renin-angiotensin system in the brain: an update. J. Renin Angiotensin Aldosterone Syst. 2 (2001) 96-102
4. Edling O., Gohlke P., Paul M., Rettig R., Stauss H.M., Steckelings U.M., and Unger T. The renin-angiotensin system: physiology and pathophysiology: physiology of the renin-angiotensin system. In: Schachter M. (Ed). ACE Inhibitors: Current Use and Future Prospects. (1995), Martin Dunitz, London 3-41
5. Ferrer I., and Planas A.M. Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra. J. Neuropathol. Exp. Neurol. 62 (2003) 329-339
6. Hara H., Huang P.L., Panahian N., Fishman M.C., and Moskowitz M.A. Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J. Cereb. Blood Flow Metab. 16 (1996) 605-611
7. Hohle S., Blume A., Lebrun C., Culman J., and Unger T. Angiotensin receptors in the brain. Pharmacol. Toxicol. 77 (1995) 306-315
8. Israels L.G., and Israels E.D. Apoptosis. Stem Cells 17 (1999) 306-313
9. Iwai M., Liu H.W., Chen R., Ide A., Okamoto S., Hata R., Sakanaka M., Shiuchi T., and Horiuchi M. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation 110 (2004) 843-848
10. Justicia C., Gabriel C., and Planas A.M. Activation of the JAK/STAT pathway following transient focal cerebral ischemia: signaling through Jak1 and Stat3 in astrocytes. Glia 30 (2000) 253-270
11. Kagiyama T., Kagiyama S., and Phillips M.I. Expression of angiotensin type 1 and 2 receptors in brain after transient middle cerebral artery occlusion in rats. Regul. Pept. 110 (2003) 241-247
12. Kane D.J., Sarafian T.A., Anton R., Hahn H., Gralla E.B., Valentine J.S., Ord T., and Bredesen D.E. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262 (1993) 1274-1277
13. Komine-Kobayashi M., Zhang N., Liu M., Tanaka R., Hara H., Osaka A., Mochizuki H., Mizuno Y., and Urabe T. Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J. Cereb. Blood Flow Metab. 26 (2006) 402-413
14. Lee J.I., and Burckart G.J. Nuclear factor kappa B: important transcription factor and therapeutic target. J. Clin. Pharmacol. 38 (1998) 981-993
15. Li J., Culman J., Hortnagl H., Zhao Y., Gerova N., Timm M., Blume A., Zimmermann M., Seidel K., Dirnagl U., and Unger T. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J. 19 (2005) 617-619
16. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ. Res. 83 (1998) 1182-1192
17. Mattson M.P., and Camandola S. NF-κB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107 (2001) 247-254
18. Nishimura Y., Ito T., and Saavedra J.M. Angiotensin II AT1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 31 (2000) 2478-2486
19. Nishimura Y., Ito T., Hoe K., and Saavedra J.M. Chronic peripheral administration of the angiotensin II AT1 receptor antagonist candesartan blocks brain AT1 receptor. Brain Res. 871 (2000) 29-38
20. Okumura M., Iwai M., Ide A., Mogi M., Ito M., and Horiuchi M. Sex difference in vascular injury and vasoprotective effect of valsartan are related to differential AT2 receptor expression. Hypertension 46 (2005) 577-583
21. Sadoshima J. Cytokine actions of angiotensin II. Circ. Res. 86 (2000) 1187-1189
22. Shuai K. Modulation of STAT signaling by STAT interacting proteins. Oncogene 19 (2000) 2638-2644
23. Suzuki S., Tanaka K., Nogawa S., Dembo T., Kosakai A., and Fukuuchi Y. Phosphorylation of signal transducer and activator of transcription-3 (Stat3) after focal cerebral ischemia in rats. Exp. Neurol. 170 (2001) 63-71
24. Walther T., Olah L., Harms C., Maul B., Bader M., Hortnagl H., Schultheiss H.P., and Mies G. Ischemic injury in experimental stroke depends on angiotensin II. FASEB J. 16 (2002) 169-176
25. Wu L., Iwai M., Nakagami H., Li Z., Chem R., Suzuki J., Gasparo M., and Horiuchi M. Roles of angiotensin II type 2 receptor stimulation associated with selective angiotensin II type 1 receptor blockade with valsartan in the improvement of inflammation-induced vascular injury. Circulation 104 (2001) 2716-2721